galactosyl-(1-3)galactose has been researched along with Scleroderma, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candela, M; Caniglia, ML; Gabrielli, A; Ricciatti, AM; Wieslander, J | 1 |
| Danieli, G; Gabrielli, A; Herrmann, K; Krieg, T; Leoni, P; Wieslander, J | 1 |
1 trial(s) available for galactosyl-(1-3)galactose and Scleroderma, Systemic
| Article | Year |
|---|---|
Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.
Topics: Disaccharides; Enzyme-Linked Immunosorbent Assay; Epitopes; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Laminin; Leishmaniasis, Cutaneous; Radioimmunoassay; Scleroderma, Systemic | 1991 |
1 other study(ies) available for galactosyl-(1-3)galactose and Scleroderma, Systemic
| Article | Year |
|---|---|
Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases.
Topics: Autoantibodies; Connective Tissue Diseases; Disaccharides; Humans; Scleroderma, Systemic | 1991 |